Drug class

Immunosuppressants - Antiproliferative Agents

Antiproliferative immunosuppressants are a therapeutic category of medications, most prominently represented by mycophenolate derivatives and azathioprine, that suppress immune activity by inhibiting purine synthesis and disrupting nucleic acid metabolism. Read more about Immunosuppressants - Antiproliferative Agents

71 drugs in this class 51 manufacturers

Advertisement

Drugs in Immunosuppressants - Antiproliferative Agents

Showing 28–36 of 71 drugs

MYCOPHENOLATE MOFETIL

IMMUNOSUPPRESSIVE INOSINE MONOPHOSPHATE DEHYDROGENASE INHIB. · PREVENTION OF KIDNEY TRANSPLANT REJECTION ·+2
Lannett Company

MYCOPHENOLATE MOFETIL

IMMUNOSUPPRESSIVE INOSINE MONOPHOSPHATE DEHYDROGENASE INHIB. · PREVENTION OF KIDNEY TRANSPLANT REJECTION ·+2
Major Pharamceuticals

MYCOPHENOLATE MOFETIL

IMMUNOSUPPRESSIVE INOSINE MONOPHOSPHATE DEHYDROGENASE INHIB. · PREVENTION OF KIDNEY TRANSPLANT REJECTION ·+2
CAMBER PHARMACE

AZATHIOPRINE

PURINE ANALOGUES · RHEUMATOID ARTHRITIS ·+1
AVKARE

MYCOPHENOLATE MOFETIL

IMMUNOSUPPRESSIVE INOSINE MONOPHOSPHATE DEHYDROGENASE INHIB. · PREVENTION OF KIDNEY TRANSPLANT REJECTION ·+2
AVPAK
Filter & compare in the drug finder → Opens the drug finder with Immunosuppressants - Antiproliferative Agents preselected. Add indication or manufacturer filters there.

About Immunosuppressants - Antiproliferative Agents.

Antiproliferative immunosuppressants are a therapeutic category of medications, most prominently represented by mycophenolate derivatives and azathioprine, that suppress immune activity by inhibiting purine synthesis and disrupting nucleic acid metabolism.

By arresting cell division, these agents selectively impair the rapid clonal expansion of activated T and B lymphocytes that lack alternative salvage pathways for nucleotide generation.

They serve as vital components of maintenance regimens to prevent allograft rejection in solid organ transplantation and are widely used to treat refractory autoimmune and inflammatory diseases, such as systemic lupus erythematosus, lupus nephritis, and rheumatoid arthritis.